IP Verse

Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate - EP3509582

The patent EP3509582 was granted to Axsome Malta on Dec 20, 2023. The application was originally filed on Sep 6, 2017 under application number EP17849432A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3509582

AXSOME MALTA
Application Number
EP17849432A
Filing Date
Sep 6, 2017
Status
Granted And Under Opposition
Nov 17, 2023
Grant Date
Dec 20, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBSep 19, 2024ADMISSIBLE

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20180623838-
DESCRIPTIONUS2012004300
DESCRIPTIONUS2014350098
DESCRIPTIONUS2015018414
DESCRIPTIONUS2016081970
DESCRIPTIONUS5705640
DESCRIPTIONUS5756817
DESCRIPTIONUS5955499
DESCRIPTIONUS6140532
DESCRIPTIONUS8232315
DESCRIPTIONUS8440715
DESCRIPTIONUS8552060
DESCRIPTIONUS8623913
DESCRIPTIONUS8729120
DESCRIPTIONUS8741950
DESCRIPTIONUS8895609
DESCRIPTIONUS8927602
DESCRIPTIONUS9226910
DESCRIPTIONUS9359290
EXAMINATIONWO2005033064
INTERNATIONAL-SEARCH-REPORTUS2014350098
INTERNATIONAL-SEARCH-REPORTUS2015246874
INTERNATIONAL-SEARCH-REPORTUS2016081970
INTERNATIONAL-SEARCH-REPORTUS6350596
OPPOSITIONUS2014275244
OPPOSITIONUS2014350098
OPPOSITIONWO2005033064
OPPOSITIONWO9607637
OTHERWO2005033064
SEARCHUS2014350098
SEARCHUS2016081970
SEARCHUS5955499

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "ICH guideline Q3C (R8) on impurities: guideline for residual solvents - Step 5", European Medicines Agency (EMA), European Medicines Agency (EMA), URL: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/ich-guideline-q3c-r8-impurities-guideline-residual-solvents-step-5_en.pdf, (20240301), XP093136693-
OPPOSITION- D10 - Rapport d'essais-
OPPOSITION- D9 - XRD of solriamfetol according to Example 1 of D1-
OPPOSITION- Heinz G. O. Becker, "2.4. Nukleophile Substitution an Alkoholen und Äthern", Heinz G. O. Becker, Heinz G. O. Becker, Organikum : organisch-chemisches Grundpraktikum, DDR, VEB Deutscher Verlag der Wissenschaften, (19810101), pages 236 - 246, XP009558305-
OPPOSITION- Schirmeister, Schmuck, Wich, "Chapter 1: Stoffe und ihre Zusammensetzung", Beyer/Walter Organische Chemie, Hirzel Verlag, (20160101), pages 1 - 9, doi:10.3813/9783777621647, ISBN 978-3-7776-1673-5, XP009558304
OPPOSITION- Schirmeister, Schmuck, Wich, "Chapter 7.1 Monohalogenalkane (Alkylhalogenide)", Beyer/Walter Organische Chemie, Hirzel Verlag, (20160101), pages 203 - 212, doi:10.3813/9783777621647, ISBN 978-3-7776-1673-5, XP009558303

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents